Nature background, abstract water drops macro.

EVIDEX®

A new standard for signal detection and management.

We’re not waiting for the future of pharmacovigilance. We’re creating it with you.

Faced with growing data volumes, evolving regulations, and the pressure to detect and act on safety signals faster than ever, today’s pharmacovigilance teams need more powerful, fit-for-purpose tools to stay ahead.

Supported by industry-leading experts in pharmacovigilance and real-world data, EVIDEX® provides a powerful, integrated signal detection and management platform.

The result? Faster, more accurate signal evaluation and a seamless path from detection to management — all in a single, compliant system.

EVIDEX® signal detection & refinement

Cut through false positives and focus on the signals that matter.

Seamlessly detect and assess the sufficiency, strength, and consistency of evidence with our time-saving, purpose-built platform.

Offering streamlined access to multiple safety databases, automated workflows, and more, EVIDEX® eliminates duplicative tasks, reduces the need for manual reviews, and allows for up to 3x faster safety reviews.

AdobeStock_621273253

EVIDEX® signal management

Navigate the complexities of signal management with confidence and compliance.

Manage, report, and share signal information with transparency and accuracy in EVIDEX®  fully GVP-IX-compliant and validated platform.

With global real-world data and expert support at your fingertips, EVIDEX® signal management capabilities simplifies one of the most complex, highly regulated processes in pharmacovigilance, reducing bottlenecks, improving efficiency, and accelerating signal reviews.

Good Pharmacovigilance Practices (GVP) module IX states that signal management processes should be adequately documented, and all steps taken should be tracked and auditable.

But when legacy systems are plagued with outdated user interfaces, long and costly implementation periods, and outdated analytic tools, how can pharmacovigilance teams reliably offer transparency into the who, what, why, and when of the process?

With its best-in-class user interface, fast, validated implementation, and an advanced data-and analytics-first approach, EVIDEX® Signal Management offers drug safety teams faster insights, stronger compliance, and greater confidence in every decision.

The EVIDEX® background rate analysis tool provides an instant, cost-effective way to calculate background incidence rates of adverse events for specific conditions — all within a validated, GVP-IX compliant platform.

Powered by real-world data from more than 125 million patients in the TriNetX dataworks (US) network, the tool delivers on-demand calculations in just a few clicks, with automation and customization built in.

Plus, if you need help, our best-in-class customer support team is on hand to guide you through this critical step in the pharmacovigilance process.

People working looking at data

Want to learn more?

Explore our latest insights

Macro image
Press Releases

Regeneron Pharmaceuticals, Inc. and TriNetX® today announced a strategic collaboration to support Regeneron’s capabilities in drug discovery and development, as well as new initiatives to deliver digital health solutions of the future for consumers, patients and providers.

Winning with RWE: What It Takes to Make Real-World Evidence Submission-Ready
Blogs

In the 2025 TriNetX and studioID survey of 150 senior biopharma executives, all participants agreed that real-world evidence has the potential to improve regulatory submissions, underscoring the urgency for sponsors to integrate RWE more strategically into their regulatory playbooks.

Glowing jellyfish close-up in the aquarium blue color.
Blogs

As 2025 wraps up, the TriNetX team is reflecting on a year of milestones, among them, being named to The Healthcare Technology Report’s Top 50 Healthcare Technology Companies list this November.

Macro image
Blogs

With Robert F. Kennedy Jr. now at the helm of the Department of Health and Human Services (HHS), his recent speech to agency staff marked the beginning of what could be a seismic shift in U.S. healthcare policy. Among his key initiatives: launching investigations into whether antidepressants and the childhood vaccine schedule are contributing to chronic diseases. 

Abstract Ocean Water Texture

Want to lean more?

Book a demo of our EVIDEX® software

"*" indicates required fields

Name*
TriNetX Marketing Opt In
By subscribing to promotional updates, you agree to the TriNetX Privacy Policy and receiving relevant TriNetX marketing and other promotional emails, from which you can opt out at any time.
TriNetX Privacy Policy*
By submitting this form, you agree to receiving marketing and other promotional emails from us. For opt-out information, as well as TriNetX privacy practices and commitment to protecting your privacy, please review the TriNetX Privacy Policy.
This field is hidden when viewing the form
From Gravity Form
This field is hidden when viewing the form
This field is hidden when viewing the form
This field is hidden when viewing the form
This field is hidden when viewing the form

Meet